To include your compound in the COVID-19 Resource Center, submit it here.

Adempas riociguat regulatory update

EMA’s CHMP recommended against the use of Adempas riociguat from Bayer to treat pulmonary hypertension

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE